PATENT CLAIM ANALYSIS

Application Number: 15769844
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "227800"]

Abstract:
A compound represented by general formula [I] wherein X represents N or the like, Y represents CH or the like; R A  represents a cycloalkyl group which may be substituted or the like, R 1  represents an alkyl group or the like, R 2  represents an alkyl group which may be substituted or the like, R 3  represents a hydrogen atom or an alkyl group, or a pharmaceutically acceptable salt thereof has an inhibitory activity on aldosterone synthetase, and is useful as a prophylactic and/or therapeutic agent for various diseases or symptoms associated with aldosterone.

Claim (Index 7):
The compound according to  claim 4 , wherein\n X is CH, Y is N, R A  is (1) an cyclohexyl group which may be substituted with an alkyl group, (2) a phenyl group which may be substituted with 1-2 groups independently selected from the group consisting of a halogen atom, an alkyl group, and a haloalkyl group, or (3) a heteroaryl group which may be partially hydrogenated and may be substituted with 1-2 groups independently selected from the group consisting of a cyano group, and an alkyl group, in the heteroaryl group which may be partially hydrogenated and may be substituted, represented by R A , the heteroaryl moiety is pyridyl, indazolyl, or benzofuranyl, R 1  is a hydrogen atom or an alkyl group, R 2  is (i) an alkyl group which may be substituted with 1-3 groups independently selected from the group consisting of a hydroxyl group; a halogen atom; and a piperidinyl group which may be substituted with 1-2 groups independently selected from the group consisting of a hydroxyl group, and an alkyl group, (ii) a cycloalkyl group which may be substituted with 1-3 groups independently selected from the group consisting of a hydroxyl group; an alkyl group which may be substituted with a hydroxyl group; an alkoxy group; an amino group which may be substituted with 1-2 groups independently selected from the group consisting of an alkyl group, and an alkanoyl group; and an aliphatic heterocyclic group which may be substituted with 1-2 oxo groups (wherein the aliphatic heterocyclic group is selected from a morpholinyl group or a piperazinyl group), (iii) an aliphatic heterocyclic group which may be substituted with 1-3 groups independently selected from the group consisting of an oxo group; an alkyl group which may be substituted with an alkylsulfonyl group; a tetrahydropyranyl group; and a pyrimidinyl group, or (iv) a pyrazolyl group which may be substituted with an alkyl group which may be substituted with a carbamoyl group which may be substituted with 1-2 alkyl groups, in the aliphatic heterocyclic group which may be substituted, represented by R 2 , the aliphatic heterocyclic moiety is pyrrolidinyl, piperidinyl, tetrahydrothiopyranyl, or 1-azabicyclo[2.2.2]octyl(quinuclidinyl), and R 3  is a hydrogen atom, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15305587', '15313407', '15779435', '10583796', '13508905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8182639516727632
- 35 USC 102 Novelty (BERT): 0.5551121362645931
- Combined Prediction Score: 0.7919487701319462
- Mean Citation Score: 322.9079480000001
- Max Citation Score: 436.3854
- Similarity Product: 341.9740086719513

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test